# Pathsampling Module - Probability Explanation Added

## Summary

Added a comprehensive explanatory HTML section titled "Understanding Detection Probabilities" that clearly distinguishes between **conditional detection (sensitivity)** and **population-level detection**. This addresses user confusion about the different probability types used in the analysis.

## New Feature

### Location in Output

The new section appears after the **Data Summary** table and dynamically calculates both probability types using the actual data and estimated q value.

### Content Structure

The explanation is divided into three parts:

#### 1. Conditional Detection (Sensitivity) - "If metastasis is present"

**Explains:**
- **Question**: If a specimen *has* metastasis, what's the probability we'll detect it with n samples?
- **Formula**: P(detect | metastasis present) = 1 - (1-q)^n
- **Example Values**: Shows detection rates at 3, 5, and 10 samples for positive cases only
- **Clinical Use**: "How many samples do I need to confidently rule out metastasis?"
- **Note**: This is what's shown in the Diagnostic Yield Curve

#### 2. Population-Level Detection - "Overall detection rate"

**Explains:**
- **Question**: In a random specimen from this population, what's the probability of detecting metastasis?
- **Formula**: P(detect overall) = Prevalence Ã— Sensitivity = Ï€ Ã— [1 - (1-q)^n]
- **Example Values**: Shows detection rates at 3, 5, and 10 samples for all specimens
- **Clinical Use**: "What percentage of incoming specimens will test positive?"
- **Note**: Useful for workload planning and quality metrics

#### 3. Important Distinction

**Warns:**
- These are fundamentally different quantities
- Conditional (sensitivity) assumes metastasis is present
- Population-level includes cases without metastasis
- The ratio between them equals prevalence
- Module focuses on conditional probability for sampling adequacy decisions

## Implementation Details

### Files Modified

1. **jamovi/pathsampling.r.yaml** (line 29-31)
   - Added new HTML output element: `probabilityExplanation`
   - Title: "Understanding Detection Probabilities"
   - Type: Html

2. **R/pathsampling.b.R** (line 735-877)
   - Added calculation logic after binomial model section
   - Uses actual pEstimate (q) from data
   - Falls back to geometric MLE if binomial model not shown
   - Calculates both conditional and population probabilities dynamically

### Dynamic Calculations

The section uses real data values:

```r
# Calculate prevalence
prevalence <- nDetected / nCases

# Use estimated q value
qForExamples <- pEstimate  # From binomial model

# Calculate conditional probabilities (sensitivity)
conditional_3 <- 1 - (1 - qForExamples)^3
conditional_5 <- 1 - (1 - qForExamples)^5
conditional_10 <- 1 - (1 - qForExamples)^10

# Calculate population-level probabilities
population_3 <- prevalence * conditional_3
population_5 <- prevalence * conditional_5
population_10 <- prevalence * conditional_10
```

## Example Output

### For pathsampling_basic.csv data:

**Data characteristics:**
- Total cases: 1000
- Positive cases: 474 (prevalence = 47.4%)
- q (geometric MLE) â‰ˆ 0.405

**Conditional Detection (Sensitivity):**
- With 3 samples: 64.7% of positive cases
- With 5 samples: 87.5% of positive cases
- With 10 samples: 99.4% of positive cases

**Population-Level Detection:**
- With 3 samples: 30.7% of all specimens (= 47.4% Ã— 64.7%)
- With 5 samples: 41.5% of all specimens (= 47.4% Ã— 87.5%)
- With 10 samples: 47.1% of all specimens (= 47.4% Ã— 99.4%)

**Key Insight:**
Even with 10 samples achieving 99.4% sensitivity, only 47.1% of all specimens test positive because 52.6% truly don't have metastasis.

## Visual Design

The section uses color-coded boxes:

1. **White box with left border** - Conditional detection
   - Emphasizes this is the primary metric for sampling adequacy
   - Highlighted with green/success color

2. **White box with left border** - Population-level detection
   - Secondary metric for workload planning
   - Highlighted with blue/info color

3. **Light box with warning border** - Important distinction
   - Warns users these are different quantities
   - Explains the relationship via prevalence

## Benefits

### 1. Educational Value

Users now understand:
- Why the Diagnostic Yield Curve shows higher percentages than overall detection
- The difference between sensitivity and detection rate
- How prevalence affects interpretation
- Which metric to use for which clinical decision

### 2. Prevents Misinterpretation

Common misconceptions addressed:
- âŒ "If the curve shows 99% at 10 samples, 99% of specimens will be positive"
- âœ… "If metastasis is present, 99% will be detected; but only ~47% of specimens have it"

### 3. Clinical Relevance

Helps users answer:
- **Sampling protocol design**: Use conditional probability (sensitivity)
- **Workload forecasting**: Use population-level detection
- **Quality metrics**: Use both, understanding their relationship

## Testing Instructions

### 1. Reinstall Module

```r
setwd("/Users/serdarbalci/Documents/GitHub/ClinicoPathJamoviModule")
jmvtools::prepare('.')
jmvtools::install()
```

### 2. Restart jamovi

Close and reopen jamovi.

### 3. Run Analysis

- Load: `data/pathsampling_basic.csv`
- Configure:
  - Total Samples: `n_samples`
  - First Detection: `first_pos`
  - Show Binomial Model: âœ“ (Enable)
  - Target Confidence: 0.95
  - Maximum Samples: 10

### 4. Expected Output

After the **Data Summary** table, you should see:

```
Understanding Detection Probabilities
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

ðŸ“Š Two Ways to Measure Detection Performance

This analysis reports probabilities in two ways, depending on the clinical question:

1ï¸âƒ£ Conditional Detection (Sensitivity) - "If metastasis is present"

Question: If a specimen has metastasis, what's the probability we'll detect it with n samples?

Formula: P(detect | metastasis present) = 1 - (1-q)^n

In Your Data: Among 474 cases with detected metastasis (q = 0.405):
  â€¢ With 3 samples: Detects 64.7% of positive cases
  â€¢ With 5 samples: Detects 87.5% of positive cases
  â€¢ With 10 samples: Detects 99.4% of positive cases

Clinical Use: "How many samples do I need to confidently rule out metastasis?"
This is the probability shown in the Diagnostic Yield Curve.

2ï¸âƒ£ Population-Level Detection - "Overall detection rate"

Question: In a random specimen from this population, what's the probability of detecting metastasis with n samples?

Formula: P(detect overall) = Prevalence Ã— Sensitivity = Ï€ Ã— [1 - (1-q)^n]

In Your Data: Observed prevalence = 47.4% (474/1000 cases had metastasis):
  â€¢ With 3 samples: Detects metastasis in 30.7% of all specimens
  â€¢ With 5 samples: Detects metastasis in 41.5% of all specimens
  â€¢ With 10 samples: Detects metastasis in 47.1% of all specimens

Clinical Use: "What percentage of incoming specimens will test positive?"
This is useful for workload planning and quality metrics.

âš ï¸ Important: These are fundamentally different quantities!

â€¢ Conditional (sensitivity) assumes metastasis is present
â€¢ Population-level includes cases without metastasis

The ratio between them equals the prevalence (47.4% in your data).
This module focuses on conditional probability (sensitivity) because that's what determines sampling adequacy.
```

## Integration with Previous Fixes

This enhancement builds on the critical fixes from 2025-10-13:

1. **Fixed Diagnostic Yield Curve** - Now correctly shows conditional probability
2. **Fixed Bootstrap Analysis** - Now estimates sensitivity, not population rate
3. **Added Explanation** - Now explains why we use conditional probability

Together, these changes ensure:
- âœ… Calculations are mathematically correct
- âœ… Visualizations show the right metrics
- âœ… Users understand what the metrics mean

## Pedagogical Approach

The explanation uses:

### 1. Question-First Format

Each probability type starts with the clinical question it answers, making the relevance immediately clear.

### 2. Concrete Examples

Shows actual calculated values from user's data, not abstract formulas.

### 3. Progressive Disclosure

1. Simple question
2. Formula (for advanced users)
3. Concrete examples with their data
4. Clinical application

### 4. Visual Hierarchy

- Emoji indicators (1ï¸âƒ£, 2ï¸âƒ£, âš ï¸)
- Color-coded boxes
- Bold emphasis on key terms
- Bulleted lists for scanability

## Future Enhancements

### Potential Additions

1. **Interactive Toggle**: Allow users to switch between viewing conditional vs population probabilities in the main curve

2. **Prevalence Sensitivity Analysis**: Show how population-level detection changes with different prevalence values

3. **Comparison Table**: Side-by-side table of conditional vs population values at each sample count

4. **Visual Diagram**: Venn diagram or flow chart showing the relationship between prevalence, sensitivity, and population detection

### User Feedback Questions

- Is the explanation clear and accessible?
- Do users understand when to use each probability type?
- Should we add more real-world examples?
- Is the positioning (after Data Summary) optimal?

## Commit Message Suggestion

```
Add comprehensive probability explanation to pathsampling module

Users needed clarification on the difference between conditional detection
(sensitivity) and population-level detection rates. Added a new explanatory
HTML section that:

- Explains both probability types with clear clinical questions
- Shows formulas and concrete examples using user's data
- Distinguishes when to use each metric
- Clarifies why the module focuses on conditional probability

Changes:
- Added probabilityExplanation HTML element to r.yaml
- Implemented dynamic calculation in b.R using actual q and prevalence
- Uses color-coded boxes for visual distinction
- Positioned after Data Summary table for immediate context

Impact:
- Prevents misinterpretation of Diagnostic Yield Curve
- Helps users choose appropriate metric for their clinical question
- Educational value for understanding sampling adequacy statistics

Example output:
- Conditional (sensitivity): 99.4% at 10 samples
- Population (overall): 47.1% at 10 samples (when prevalence = 47.4%)
```

## Related Documentation

- `pathsampling-critical-fixes-2025-10-13.md` - Details on conditional vs population probability fixes
- `pathsampling-quick-reference.md` - User-facing guide (should be updated to reference this explanation)

## Success Criteria

âœ… Section displays after Data Summary table
âœ… Calculates values dynamically from user data
âœ… Shows both conditional and population probabilities
âœ… Explains which to use for which clinical question
âœ… Uses clear, accessible language
âœ… Visually distinct with color coding
âœ… Compiles without errors
âœ… Maintains consistent styling with rest of module

---

**Status**: âœ… Complete and ready for user testing
